- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-1-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-4)][alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.11: 8 residues within 4Å:- Chain E: E.216, V.259, L.266, N.267, G.383, C.448, V.449, S.450
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.17: 8 residues within 4Å:- Chain G: K.69, L.266, N.267, C.382, R.447, C.448, V.449, S.450
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:V.449
- Hydrogen bonds: G:K.69, G:K.69, G:V.449, G:Q.443
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.23: 2 residues within 4Å:- Chain C: E.92, N.93
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain C: N.138, K.152, N.193
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain C: W.101, N.239, T.241, S.279
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain C: N.281, N.284
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.306, I.327, V.445
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain C: A.340, N.343, S.413
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain C: N.359, S.401, T.403, S.404
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain C: N.367, S.368, N.390, S.392
- Ligands: NAG-NAG.7, NAG-NAG.7
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain C: S.392, N.396
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain C: Q.298, V.449, S.450, N.451
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain C: E.273, N.294, E.295
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain D: N.102, S.103, T.104
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain D: K.124, E.125, I.126, S.127, N.128
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain E: E.92, N.93
- Chain F: G.18, S.19
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain E: T.137, N.138
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain E: N.141, N.142
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain E: F.156, N.157, K.166, Q.167, K.168
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain E: N.281, T.283
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain E: Q.298, N.300, N.336, V.337, S.338
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain E: N.306, I.327, V.445
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain E: N.343, W.399
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain E: R.354, K.355, N.359
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain E: N.390, S.392, R.422
- Ligands: NAG-NAG.13, NAG-NAG.13
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain E: S.392, G.393, N.396
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain E: E.274, N.294, E.295
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain E: W.101, N.239, T.241, S.279, I.282
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain F: K.124, E.125, S.127, N.128
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain F: N.107, R.108, N.109
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain G: E.92, N.93
- Chain H: G.18, S.19
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain G: S.155, F.156, N.157, K.168
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain A: X.54
- Chain C: R.313
- Chain G: R.197, N.202
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain G: N.239, T.241, S.279
Ligand excluded by PLIPNAG.55: 5 residues within 4Å:- Chain G: E.272, E.273, N.294, E.295, K.348
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain G: Q.298, N.300, R.447
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain G: N.306, I.327, V.445
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain G: R.354, G.358, N.359
Ligand excluded by PLIPNAG.59: 6 residues within 4Å:- Chain G: T.376, N.390, S.392
- Ligands: NAG-NAG-NAG.20, NAG-NAG-NAG.20, NAG-NAG-NAG.20
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain G: V.449, S.450, N.451
Ligand excluded by PLIPNAG.61: 3 residues within 4Å:- Chain G: S.463, T.464, N.465
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain G: H.90, N.246
Ligand excluded by PLIPNAG.63: 4 residues within 4Å:- Chain G: A.340, N.343, T.403, T.411
Ligand excluded by PLIPNAG.64: 4 residues within 4Å:- Chain H: P.100, W.101, N.102, T.104
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain H: N.109, S.111, E.112
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- NHP gp120-Interface Epitope pAb - Predicted Heavy Chain: A
NHP gp120-Interface Epitope pAb - Predicted Light Chain: B
Surface protein gp120: CEG
Transmembrane protein gp41: DFH
NHP V5 Epitope pAb - Predicted Light Chain: I
NHP V5 Epitope pAb - Predicted Heavy Chain: J
NHP Anti-Immune Complex pAb - Predicted Heavy Chain: K
NHP Anti-Immune Complex pAb - Predicted Light Chain: L - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CG
ED
BF
DH
FI
GJ
IK
JL
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-1-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-4)][alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- NHP gp120-Interface Epitope pAb - Predicted Heavy Chain: A
NHP gp120-Interface Epitope pAb - Predicted Light Chain: B
Surface protein gp120: CEG
Transmembrane protein gp41: DFH
NHP V5 Epitope pAb - Predicted Light Chain: I
NHP V5 Epitope pAb - Predicted Heavy Chain: J
NHP Anti-Immune Complex pAb - Predicted Heavy Chain: K
NHP Anti-Immune Complex pAb - Predicted Light Chain: L - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CG
ED
BF
DH
FI
GJ
IK
JL
K